OPKO Health (OPK) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.80 +4.65%
Revenue Growth %: -9.9%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -9.9%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of $0.01, $0.09 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.1 million versus the consensus estimate of $156.35 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- SMX to begin trading post-reverse split on Nov. 9 at 2.8:1 ratio
- Gordon Haskett Upgrades Wayfair (W) to Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
